Procter & Gamble Hygiene and Health Care Limited has informed the Exchange regarding Change in Director(s) of the company.
PGHH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Procter & Gamble Hygiene and Health Care Limited, at its meeting on July 30, 2025, approved the re-appointment of Mr. Chittranjan Dua as an Independent Director for a second term of five years, effective August 25, 2025 to August 24, 2030. This re-appointment follows the completion of his first tenure and is subject to shareholder approval at the upcoming annual general meeting. The company has confirmed that Mr. Dua meets the independence criteria under Section 149 of the Companies Act, 2013, and SEBI LODR Regulations, and is not debarred from holding directorship by SEBI or MCA. He does not hold any shares in the company, and no other director is related to him.
This is a routine governance disclosure with no material impact on shareholders or the stock price. The continuity of an independent director provides board stability and is generally viewed as neutral to positive for corporate governance.